Los anlisis de subgrupos recientes del ensayo AMPLITUDE-O demuestran un beneficio igual de efpeglenatida frente a placebo con respecto a MACE en pacientes con y sin tratamiento inicial de iSGLT2 (AMPLITUDE-O randomiz pacientes estratificados en relacin con el uso de SGLT2i)
Reference: Chen, T.-H., Wang, H.-C., Chang, C.-J., & Lee, S.-Y
For instance, if you opted for IV therapy due to fatigue, you should feel more alert and energetic before your treatment ends
Although rare in developed countries, pellagra remains endemic in poorer regions, with risk factors including low socioeconomic status, alcoholism, anorexia nervosa, cancer, and malabsorptive disorders, such as Crohns disease, as well as the use of some specific medications such as immunosuppressive and anti-tuberculosis drugs (54)
The FDA has taken a strict approach to enforcing regulations in this space